Patents by Inventor Mark D. Brennan

Mark D. Brennan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pattern Forming For Heterogeneous Erase Blocks
    Publication number: 20240134569
    Abstract: A method of using flash storage devices with different sized erase blocks is provided. The method includes allocating a plurality of erase blocks of heterogeneous erase block sizes to a RAID stripe, to form a tile pattern having the heterogeneous erase block sizes in the RAID stripe. The method includes writing the RAID stripe across the flash storage devices in accordance with the allocating, and stopping the writing the RAID stripe, responsive to contents of the RAID stripe reaching a threshold.
    Type: Application
    Filed: July 12, 2023
    Publication date: April 25, 2024
    Inventors: ERIC D. SEPPANEN, ANDREW R. BERNAT, TIMOTHY W. BRENNAN, MARK L. McAULIFFE, NEIL BUDA VACHHARAJANI
  • GENETIC MARKERS OF ANTIPSYCHOTIC RESPONSE
    Publication number: 20160122821
    Abstract: Provided herein are genetic markers for predicting response to antipsychotic treatment. Identification of the disclosed SNPs can be used to predict response to antipsychotic drugs in patients suffering from schizophrenia.
    Type: Application
    Filed: June 10, 2014
    Publication date: May 5, 2016
    Applicant: SUREGENE, LLC
    Inventors: Qian LIU, Mark D. BRENNAN
  • Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic Signature
    Publication number: 20130090329
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a OPRP genetic signature are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the genetic signature.
    Type: Application
    Filed: October 7, 2011
    Publication date: April 11, 2013
    Applicant: SUREGENE, LLC
    Inventors: Timothy L. Ramsey, Bharat Mehrotra, Mark D. Brennan
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE SULT4A1-1 HAPLOTYPE
    Publication number: 20120277211
    Abstract: Methods and compositions that relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Application
    Filed: November 4, 2010
    Publication date: November 1, 2012
    Applicant: SUREGENE LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE OLANZAPINE POOR RESPONSE PREDICTOR GENE SIGNATURE
    Publication number: 20120094854
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a OPRP genetic signature are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the genetic signature.
    Type: Application
    Filed: April 25, 2011
    Publication date: April 19, 2012
    Applicant: SUREGENE, LLC
    Inventors: Timothy L. Ramsey, Bharat Mehrotra, Mark D. Brennan
  • Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
    Patent number: 7985551
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: July 26, 2011
    Assignee: Suregene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
    Patent number: 7972793
    Abstract: Methods and compositions that relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: July 5, 2011
    Assignee: Suregene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
    Patent number: 7951542
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: May 31, 2011
    Assignee: Surgene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
    Patent number: 7951543
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: May 31, 2011
    Assignee: Suregene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE SULT4A1-1 HAPLOTYPE
    Publication number: 20110105468
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Application
    Filed: August 18, 2010
    Publication date: May 5, 2011
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE SULT4A1-1 HAPLOTYPE
    Publication number: 20110105467
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Application
    Filed: August 18, 2010
    Publication date: May 5, 2011
    Inventors: TIMOTHY L. RAMSEY, MARK D. BRENNAN
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE SULT4A1-1 HAPLOTYPE
    Publication number: 20110105469
    Abstract: Methods and compositions that relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Application
    Filed: November 3, 2010
    Publication date: May 5, 2011
    Applicant: Suregene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE SULT4A1-1 HAPLOTYPE
    Publication number: 20110105466
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Application
    Filed: November 4, 2009
    Publication date: May 5, 2011
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature
    Patent number: 7932042
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a OPRP genetic signature are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the genetic signature.
    Type: Grant
    Filed: October 13, 2010
    Date of Patent: April 26, 2011
    Assignee: Suregene, LLC
    Inventors: Timothy L. Ramsey, Bharat Mehrotra, Mark D. Brennan
  • Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
    Patent number: 7790396
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: September 7, 2010
    Assignee: Suregene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan